Urinary hydroxyproline and thyroid disease

Goldie, D J; Pennock, C A
February 1971
British Medical Journal;2/13/1971, Vol. 1 Issue 5745, p404
Academic Journal
No abstract available.


Related Articles

  • Treatment of Paget's Disease of Bone with once a week Injections of Salmon Calcitonin. Avramides, Avraam; Flores, Adelina; Debrose, Joseph; Wallach, Stanley // British Medical Journal;9/13/1975, Vol. 3 Issue 5984, p632 

    Investigates the effectiveness of salmon calcitonin in the treatment of patients with Paget's disease of bone in New York, New York. Decrease in urinary hydroxyproline and serum calcium; Failure of three patients to decrease total hydroxyproline; Clinical and biochemical characteristics of...

  • Urinary hydroxyproline as a Non-Invasive Biomarker for diagnosing Osteofluorosis in Bovines. Gupta, A. R.; Dey, S.; Saini, M.; Swarup, D. // Intas Polivet;jul-dec2012, Vol. 13 Issue 2, p354 

    Urinary hydroxyproline an index for bone metabolism was determined in cattle from fluoride endemic area. Cattle (n=12) were divided in two equal groups of six animals each. Group I and II served as healthy and disease control, respectively. Urine samples were collected from both groups for...

  • Hydroxyproline and Collagen Metabolism. Sjoerdsma, Albert; Udenfriend, Sidney; Keiser, Harry; LeRoy, E. Carwile // Annals of Internal Medicine;Oct65, Vol. 63 Issue 4, p672 

    Presents a transcription of a clinical staff conference at the Clinical Center in Bethesda, Maryland, about the clinical implications of hydroxyproline and collagen metabolism. Mechanism of conversion of proline to collagen hydroxyproline; Specificity of the collagenase procedure; Discussion of...

  • Increase of urinary and serum hydroxyproline in subjects exposed to cadmium. Nishino, H.; Tanaka, T.; Shiroishi, K.; Sato, S.; Naruse, Y.; Kagamimori, S. // Bulletin of Environmental Contamination & Toxicology;Oct1991, Vol. 47 Issue 4, p609 

    The article presents a study which examines the increased concentrations of urinary and serum hydroxyproline resulting from cadmium (Cd) exposure. The study investigated CD-exposed group which consists 12 female I disease patients and 13 female so-called I disease observation patients. The study...

  • Effect of Alcohol on Total Urinary Hydroxyproline Excretion. Wu, A.; Levi, A. J. // American Journal of Gastroenterology;Sep1975, Vol. 64 Issue 3, p217 

    Presents a study regarding the effect of alcohol on total urinary hydroxyproline excretion. Characteristic features of cirrhosis produced by alcohol; Total urinary hydroxyproline excretion in a number of alcoholics while drinking and then withdrawn from alcohol.

  • Thyroid Troubles. Cimons, Marlene // Runner's World;Dec2001, Vol. 36 Issue 12, p36 

    Provides information on thyroid disease.

  • Hydroxyproline Excretion in Patients with Breast Cancer and Response to Treatment. Powles, T.J.; Leese, C.L.; Bondy, P.K. // British Medical Journal;4/26/1975, Vol. 2 Issue 5964, p164 

    Focuses on the use of measured urinary excretion of hydroxyproline in monitoring the progression of metastatic breast cancer in Great Britain. Pathomechanics of breast tumor break down; Factors influencing hydroxyproline excretion; Information on bone destruction in relation with tumor treatment.

  • Thyrotoxicosis presenting as fracture of femoral neck. Francis, R.M.; Barnett, M.J.; Selby, P.L.; Peacock, M. // British Medical Journal (Clinical Research Edition);7/10/1982, Vol. 285 Issue 6335, p97 

    Examines the thyrotoxicosis fracture of the femoral neck in patients. Evidence of bone resorption with high fasting urinary hydroxyproline creatinine ratio; Effect of carbimazole treatment on the hydroxyproline creatinine ratio.

  • Bone Demineralization in Postmenopausal Women: Role of Anamnestic Risk Factors. Vignera, Sandro La; Condorelli, Rosita A.; Vicari, Enzo; Nicoletti, Chiara; Calogero, Aldo E. // International Journal of Endocrinology;2012, p1 

    This study evaluated the effects of LT4 administration on the bone mineral density (BMD) in physiological postmenopausal women after two years of continuative treatment. 110 postmenopausal women with nodular goiter aged between 50 and 55 years were examined before and after 2 years of therapy...

  • Serum Digoxin in Patients with Thyroid Disease. Croxson, M.S.; Ibbertson, H.K. // British Medical Journal;9/6/1975, Vol. 3 Issue 5983, p566 

    Investigates the influence of renal function on serum digoxin levels in patients with thyroid disease. Measurement of serum digoxin concentrations; Analysis of the changes in glomerular filtration rate and digoxin serum; Application of radioimmunoassay for serum and urinary digoxin measurements.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics